Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00173) | |||||
---|---|---|---|---|---|
Name |
Deferiprone
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
deferiprone; 30652-11-0; 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone; Ferriprox; 3-hydroxy-1,2-dimethylpyridin-4(1H)-one; 1,2-dimethyl-3-hydroxy-4-pyridone; 1,2-Dimethyl-3-hydroxypyrid-4-one; 1,2-Dimethyl-3-hydroxypyridine-4-one; 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-; APO-66; APO-066; UNII-2BTY8KH53L; DN-180-01-AF; MFCD00134497; Deferiprone (INN); CHEBI:68554; 1,2-Dimethyl-3-hydroxy-4(1H)-pyridinone; 3-hydroxy-1,2-dimethylpyridin-4-one; 2BTY8KH53L; MLS000069481; 4(1H)-Pyridinone, 1,2-dimethyl-3-hydroxy-; DN-18001AF; SMR000059136; 1,2-Dimethyl-3-hydroxy-4-pyridone, 99+%; CP20 (Chelating agent); Ferriprox (TN); 3-hydroxy-1,2-dimethylhydropyridin-4-one; BRN 1447108; Deferum; Deferiprone [USAN:INN:BAN]; CCRIS 8318; 1,2-dimethyl-3-hydroxy-4-pyridinone; 3-Hydroxy-1,2-dimethyl-4-pyridinone; L-1[chelating agent]; ACMC-209hhl; Opera_ID_366; 3-hydroxy-1,2-dimethyl-4(1H)-pyridinone; Deferiprone (USAN/INN); DSSTox_CID_20666; DSSTox_RID_79529; DSSTox_GSID_40666; SCHEMBL94474; MLS000758227; MLS001424029; MLS006011689; CHEMBL70927; CRMD-001; GTPL7456; ZINC6226; DTXSID6040666; HSDB 8335; TZXKOCQBRNJULO-UHFFFAOYSA-; EX-A972; HMS2051C05; HMS2232E24; HMS3264P17; HMS3393C05; HMS3873L13; Pharmakon1600-01504512; BCP09606; HY-B0568; 3-hydroxy-1,2-dimethylpyrid-4-one; Tox21_112429; 3231AB; ANW-26935; BBL036482; BDBM50525976; CGP-37391; NSC758880; SBB006753; STL559018; 1,2-dimetyl-3-hydroxy-4-pyridinone; AKOS015902286; CCG-100760; CS-5240; DB08826; DS-5493; MCULE-6406005067; NC00010; NSC-758880; VP13942; 3-hydroxy-1,2-dimethyl-4- pyridinone; 3-hydroxy-1,2-dimethyl-pyridin-4-one; NCGC00090548-01; NCGC00090548-02; NCGC00090548-04; AC-33026; AK112338; BP-12415; ST093416; SY052576; SBI-0207041.P001; CAS-30652-11-0; DB-047826; FT-0606424; D07416; 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone, 98%; AB00572605_11; AB00572605_12; Q749664; SR-01000721891; 4(1H)-Pyridone, 3-hydroxy-1,2-dimethyl- (8CI); Deferiprone 1,2-DIMETHYL-3-HYDROXY-4-PYRIDONE; SR-01000721891-4; tert-Butyl2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Thalassaemia | ICD-11: 3A50 | [1] | ||
PubChem CID | |||||
Formula |
C7H9NO2
|
||||
Canonical SMILES |
CC1=C(C(=O)C=CN1C)O
|
||||
InChI |
1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3
|
||||
InChIKey |
TZXKOCQBRNJULO-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2972"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 139.15 | Topological Polar Surface Area | 40.5 | |
XlogP | 0.5 | Complexity | 228 | ||
Heavy Atom Count | 10 | Rotatable Bond Count | 0 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Deferiprone 500 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Titanium dioxide; Polyethylene glycol 3350; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2910 (15000 mpa.s)
|
|||||
Dosage Form | Oral Tablet | |||||
Company | ApoPharma USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.